| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
1 Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Department of Clinical Molecular Medicine and 2 Division of Molecular Pathology, Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan; 3 Tumor Endocrinology Project, National Cancer Center Research Institute, Tokyo, Japan; and 4 Departments of Medicine, Physiology, and Human Genetics, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada
Primary hyperparathyroidism is a common endocrine disorder caused by parathyroid gland enlargement and excessive parathyroid hormone (PTH) secretion. However, the precise mechanisms of tumorigenesis of the parathyroids are unknown. Here we have investigated the roles of transforming growth factor (TGF)-ß and menin, the product of the multiple endocrine neoplasia type 1 (Men1) gene, in the proliferation and PTH production of parathyroid cells from either patients with secondary hyperparathyroidism or Men1. TGF-ß was expressed in the parathyroid endocrine cells. Addition of TGF-ß to parathyroid cells from patients with secondary hyperparathyroidism inhibited their proliferation and PTH secretion. These responses to TGF-ß were lost when menin was specifically inactivated by antisense oligonucleotides. Moreover, TGF-ß did not affect the proliferation and PTH production of parathyroid cells from a Men1 patient. These results indicate that menin is required for TGF-ß action in the parathyroid. We conclude that TGF-ß is an important autocrine/paracrine negative regulator of parathyroid cell proliferation and PTH secretion and that loss of TGF-ß signaling due to menin inactivation contributes to parathyroid tumorigenesis.
This article has been cited by other articles:
![]() |
S. Fontaniere, B. Duvillie, R. Scharfmann, C. Carreira, Z.-Q. Wang, and C.-X. Zhang Tumour suppressor menin is essential for development of the pancreatic endocrine cells J. Endocrinol., November 1, 2008; 199(2): 287 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hussein, J. Lu, H. Casse, S. Fontaniere, A.-M. Morera, S. M. Guittot, A. Calender, N. Di Clemente, and C. X Zhang Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice Endocr. Relat. Cancer, March 1, 2008; 15(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, E. W. Arvisais, C. Jiang, D.-b. Chen, S. K. Roy, J. L. Pate, T. R. Hansen, B. R. Rueda, and J. S. Davis Prostaglandin F2{alpha} Stimulates the Expression and Secretion of Transforming Growth Factor B1 Via Induction of the Early Growth Response 1 Gene (EGR1) in the Bovine Corpus Luteum Mol. Endocrinol., February 1, 2008; 22(2): 403 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papaconstantinou, Y. Wu, H. N. Pretorius, N. Singh, G. Gianfelice, R. M. Tanguay, A. R. Campos, and P.-A. Bedard Menin Is a Regulator of the Stress Response in Drosophila melanogaster Mol. Cell. Biol., November 15, 2005; 25(22): 9960 - 9972. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Naito, H. Kaji, H. Sowa, G. N. Hendy, T. Sugimoto, and K. Chihara Menin Suppresses Osteoblast Differentiation by Antagonizing the AP-1 Factor, JunD J. Biol. Chem., February 11, 2005; 280(6): 4785 - 4791. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |